There is no better tap than Vincerx Pharma Inc (VINC) Stock
H.C. Wainwright raised the price target for the Vincerx Pharma Inc (NASDAQ:VINC) stock to “a Buy”. The rating was released on January 14, 2022, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $24. The stock was initiated by Laidlaw, who disclosed in […]
Vincerx Pharma Inc (NASDAQ:VINC) Stock lower -24.01% in This Year: What’s Happened?
H.C. Wainwright raised the price target for the Vincerx Pharma Inc (NASDAQ:VINC) stock to “a Buy”. The rating was released on January 14, 2022, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $24. The stock was initiated by Laidlaw, who disclosed in […]
Vincerx Pharma Inc (NASDAQ:VINC) stock is trading 60.66 percent above its 52-week low
H.C. Wainwright raised the price target for the Vincerx Pharma Inc (NASDAQ:VINC) stock to “a Buy”. The rating was released on January 14, 2022, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $24. The stock was initiated by Laidlaw, who disclosed in […]
Vincerx Pharma Inc (NASDAQ:VINC) Stock initiated by H.C. Wainwright
H.C. Wainwright raised the price target for the Vincerx Pharma Inc (NASDAQ:VINC) stock to “a Buy”. The rating was released on January 14, 2022, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $24. The stock was initiated by Laidlaw, who disclosed in […]
Why Vincerx Pharma Inc (NASDAQ:VINC) Stock Decreased -6.25 percent in recent Trade?
H.C. Wainwright raised the price target for the Vincerx Pharma Inc (NASDAQ:VINC) stock to “a Buy”. The rating was released on January 14, 2022, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $24. The stock was initiated by Laidlaw, who disclosed in […]
Why Vincerx Pharma Inc (NASDAQ:VINC) Stock down -7.16% in Last Week?
H.C. Wainwright raised the price target for the Vincerx Pharma Inc (NASDAQ:VINC) stock to “a Buy”. The rating was released on January 14, 2022, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $24. The stock was initiated by Laidlaw, who disclosed in […]
